LIfT Biosciences Establishes Scientific Advisory Board to Accelerate Development of Neutrophil-based Cancer Therapies
· lift biosciences
AI Briefing
- LIfT BioSciences establishes Scientific Advisory Board to accelerate development of Neutrophil-based cancer therapies.
- The SAB brings expertise from Nobel laureate James P. Allison and other globally-recognised experts in cancer immunotherapy and immunology.
- The group will provide strategic and scientific guidance on LIfT's lead IMAN programme for HNSCC and cervical cancer.
Advertisement